- Bevorzugter Name
- Avilamycin B
- IUPAC
- [(2R,3S,4R,6S)-6-[(2'R,3'S,3aR,4R,4'R,6S,7aR)-6-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5S,6S)-6-[(2R,3aS,3'aR,6S,6'R,7R,7'S,7aR,7'aR)-7'-acetyl-7-acetyloxy-7'-hydroxy-6'-methylspiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,4'-6,7a-dihydro-3aH-[1,3]dioxolo[4,5-c]pyran]-6-yl]oxy-4-hydroxy-5-methoxy-2-(methoxymethyl)oxan-3-yl]oxy-3-hydroxy-5-methoxy-6-methyloxan-4-yl]oxy-4'-hydroxy-2',4,7a-trimethylspiro[3a,4,6,7-tetrahydro-[1,3]dioxolo[4,5-c]pyran-2,6'-oxane]-3'-yl]oxy-4-hydroxy-2-methyloxan-3-yl] 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate
- Englischer Name
- Avilamycin B
- Summenformel
- C59H84Cl2O32
- Molmasse
- 1376.19
Namen und Synonyme
Curamycin AAVILAMYCIN B09Q4B44I8C73240-30-9DTXSID40223473CHEBI:71987RefChem:128856DTXCID40145964((2R,3S,4R,6S)-6-((2'R,3'S,3aR,4R,4'R,6S,7aR)-6-((2S,3R,4R,5S,6R)-2-((2R,3S,4S,5S,6S)-6-((2R,3aS,3'aR,6S,6'R,7R,7'S,7aR,7'aR)-7'-acetyl-7-acetyloxy-7'-hydroxy-6'-methylspiro(4,6,7,7a-tetrahydro-3aH-(1,3)dioxolo(4,5-c)pyran-2,4'-6,7a-dihydro-3aH-(1,3)dioxolo(4,5-c)pyran)-6-yl)oxy-4-hydroxy-5-methoxy-2-(methoxymethyl)oxan-3-yl)oxy-3-hydroxy-5-methoxy-6-methyloxan-4-yl)oxy-4'-hydroxy-2',4,7a-trimethylspiro(3a,4,6,7-tetrahydro-(1,3)dioxolo(4,5-c)pyran-2,6'-oxane)-3'-yl)oxy-4-hydroxy-2-methyloxan-3-yl) 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoatebeta-D-Mannopyranoside, O-(1R)-4-C-acetyl-6-deoxy-2,3-O-methylene-D-galactopyranosylidene-(1-3-4)-2-O-acetyl-alpha-L-lyxopyranosyl O-2,6-dideoxy-4-O-(3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoyl)-beta-D-arabino-hexopyranosyl-(1-4)-O-2,6-dideoxy-D-arabino-hexopyranosylidene-(1-3-4)-O-2,6-dideoxy-3-C-methyl-beta-D-arabino-hexopyranosyl-(1-3)-O-6-deoxy-4-O-methyl-beta-D-galactopyranosyl-(1-4)-2,6-di-O-methyl-